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Obtaining control of cell surface 
functionalizations via Pre-targeting 
and Supramolecular host guest 
interactions
Mark T. M. Rood1,*, Silvia J. Spa1,*, Mick M. Welling1, Jan Bart ten Hove1,2, Danny M. van 
Willigen1, Tessa Buckle1, Aldrik H. Velders1,2 & Fijs W. B. van Leeuwen1,2
The use of mammalian cells for therapeutic applications is finding its way into modern medicine. 
However, modification or “training” of cells to make them suitable for a specific application remains 
complex. By envisioning a chemical toolbox that enables specific, but straight-forward and generic 
cellular functionalization, we investigated how membrane-receptor (pre)targeting could be combined 
with supramolecular host-guest interactions based on β-cyclodextrin (CD) and adamantane (Ad). 
The feasibility of this approach was studied in cells with membranous overexpression of the 
chemokine receptor 4 (CXCR4). By combining specific targeting of CXCR4, using an adamantane (Ad)-
functionalized Ac-TZ14011 peptide (guest; KD = 56 nM), with multivalent host molecules that entailed 
fluorescent β-CD-Poly(isobutylene-alt-maleic-anhydride)-polymers with different fluorescent colors 
and number of functionalities, host-guest cell-surface modifications could be studied in detail. A second 
set of Ad-functionalized entities enabled introduction of additional surface functionalities. In addition, 
the attraction between CD and Ad could be used to drive cell-cell interactions. Combined we have shown 
that supramolecular interactions, that are based on specific targeting of an overexpressed membrane-
receptor, allow specific and stable, yet reversible, surface functionalization of viable cells and how this 
approach can be used to influence the interaction between cells and their surroundings.
Cells are the cornerstones of mammalian life forms, their versatile surfaces are naturally evolved to express mol-
ecules which provide a refined means to interact with their surroundings, e.g. functionalizations1. These func-
tionalities can stimulate and/or respond to cellular activity2, regulate vital processes such as hormone balance3,4 
and induce immune responses5,6. The strength of using cells for therapeutic purposes is progressively being rec-
ognized in medicine and is (among others) exploited in the form of immunotherapy and (stem) cell transplanta-
tions7–9. The implantation of (stem) cells allows regeneration of the impaired tissue, however therapy efficiency 
is limited by low engraftment of the cells at the site of interest10. Furthermore, such cell-based therapies often 
go hand-in-hand with relatively complex biological modification processes such as genetic modification11 or 
metabolic labeling12. As each medical application desires specialized features and functions, these modification 
processes match an individual cell type to a specific application. To enhance delivery and local retention to the site 
of interest, ideally an interaction-enhancing functionalization can be introduced in a cell-type specific manner, 
using well defined and generic (chemical) functionalization approaches13.
By recognizing the cell surface as a (complex) chemical scaffold, one can reason that its functionality and 
interactions can be altered via bio-orthogonal conjugations14–16. Known examples are the introduction of polye-
lectrolyte polymers14,17–19 and the insertion of lipophilic anchors containing a functional group such as integrins 
or reactive handles20–24. Alternatively, one could approach cell functionalization in a way similar to the function-
alization of inorganic surfaces. The opposite has been used extensively; hereby inorganic surfaces with simulated 
cell surfaces have been applied to mimic interactions that occur in nature25–27. When controllable and reversible 
inorganic-surface modifications are desired in aqueous environments, supramolecular host-guest interactions, 
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e.g. using beta-cyclodextrin (β -CD) and adamantane (Ad), provide outcome28–33. Especially when one considers 
that CD based host-guest interactions also play a key role in the preparation of biomedical materials and in drug 
delivery33–35.
Membrane-expressed biomarkers provide a unique fingerprint for cell populations and allow efficient and 
specific targeting using vectors such as antibody-derivatives and peptides36. Such vectors are routinely used for 
applications in imaging and therapy37. Not only can specificity be achieved by direct targeting of the receptor, 
indirect targeting can also be applied in a pre-targeting setup38. Here a receptor-targeting vector is first directed 
towards the membrane-receptor. This first targeting step is then followed by a secondary functionalization, using 
an agent that contains e.g. a diagnostic or a therapeutic label38–40. Other than applying the pre-targeting concept 
to introduce such diagnostic/therapeutic labels, potentially the same concept could also be utilized to introduce 
other functionalities on the cell surfaces.
We reasoned that it would be possible to functionalize cell surfaces in a similar way to what is known for inor-
ganic surfaces. To realize this, a combination of membrane receptor-(pre)targeting and supramolecular surface 
functionalization techniques were used. Herein the chemokine receptor 4 (CXCR4)41, a receptor that plays a 
key role in cellular motility as result of chemotaxis, served as the membrane receptor. Specific functionalization 
of CXCR4 was achieved via the use of an adamantane functionalized Ac-TZ14011 peptide (Fig. 1a1). Further 
Figure 1. (a) Schematic representation of the supramolecular functionalization of cell surfaces via targeting 
of the membrane-receptor CXCR4 (green). As first step, cellular specificity is introduced by using Ac-
TZ14011-Ad (1) peptide to target CXCR4 (step 1). This provides an Ad-functionality on the surface that can be 
used as basis for more generic functionalization with β -CD polymers containing variable fluorescent labels and 
β -CD; Cy50.5CD10PIBMA39 (3). Cy31.5CD72PIBMA389 (4) (step 2; x = 10 or 72). The then artificially generated 
CD-surfaces can be used to drive cellular interactions with entities containing matching guest functionalities. 
Hereby a third generation of functionalization can be introduced such as Ad-functionalized fluorescent dye 
(step 3) or cell-cell interactions can be induced with Ad-functionalized cells (step 4). (b) Chemical structures 
of the key compounds; Ac-TZ14011-Ad (1), Cy50.5CD10PIBMA39 (3), Cy31.5CD72PIBMA389 (4) and 
Cy50.4PIBMA39 (2), the polymer-units containing different functionalities are randomly distributed within the 
polymer. In Ac-TZ14011-Ad the pharmacophore of Ac-TZ14011 is indicated in purple. The main guest for β 
-CD; Ad is indicated by a pink solid line, together with a possible second guest: Tyr10 (pink dotted line).
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surface functionalization was based on the host-guest interaction between beta-cyclodextrin host molecules on 
fluorescent beta-cyclodextrin-Poly(isobutylene-alt-maleic-anhydride)-polymers and the adamantane function-
ality (Fig. 1a2). We also illustrate how such an approach enables the introduction of additional surface function-
alities (e.g. diagnostic labels) and can even be used to drive cell-cell interactions.
Results and Discussion
Design and synthesis of the chemical components. The cyclic Ac-TZ14011 peptide, a well-known 
targeting ligand for the CXCR4 receptor41, was functionalized using an Ad-group (Fig. 1b). Hereby the Ad-group 
pointed outwards from the pharmacophore42, making the Ad-group available for interactions with the cell’s envi-
ronment. Flow cytometry-based competition experiments on viable CXCR4 expressing cells (MDAMB231 × 4), 
revealed a KD of 56 nM for Ac-TZ14011-Ad (Supplementary Fig. S11), using the fluorescent Ac-TZ14011-MSAP 
(KD = 187 nM) as a reference. Unmodified Ac-TZ14011 has an affinity of 8.6 nM43, which indicates that the intro-
duction of the Ad functionality only has a relatively small adverse effect on the receptor affinity41.
Poly(isobutylene-alt-maleic-anhydride) (PIBMA) with different lengths (PIBMA39 and PIBMA389) were 
used for the polymer backbone, as the anhydrides allow easy grafting with nucleophiles such as β -CD-NH2, 
Cy3-NH2 and Cy5-NH2. Furthermore, hydrolyzing the non-reacted anhydrides to carboxylates, provides 
good solubility in aqueous solutions (pKa1 = 4)44,45. This approach resulted in the synthesis of two fluorescent 
β -CD-PIBMA-polymers and one solely fluorescent PIBMA39-polymer without β -CD for control experiments. 
After conjugation, absorption spectroscopy revealed that on average 0.5 Cy5, 1.5 Cy3, and 0.4 Cy5 fluorophores 
were conjugated to the respective polymers. 1H-NMR and NMR Diffusion Ordered Spectroscopy (DOSY) were 
used to determine the degree of CD-functionalization and to estimate the hydrodynamic diameter of the respective 
polymers. This yielded one polymer with 10 β -CD-units with diameter ~2.8 nm (~18.8 kDa: Cy50.5CD10PIBMA39), 
one polymer with 72 β -CD-units with diameter ~11.7 nm (~155 kDa; Cy31.5CD72PIBMA389), and one polymer 
without β -CD-units with diameter ~2.7 nm (~7.8 kDa; Cy50.4PIBMA39)(Fig. 1b).
Functionalization of cell surfaces. To prove that (supramolecular) cell-surface modification becomes 
possible via specific functionalization of the membrane-receptors, CXCR4 overexpressing MDAMB231 × 4 cells 
were functionalized in two steps; first with Ac-TZ14011-Ad (1 h; 0 °C), to allow for CXCR4 receptor targeting 
(Fig. 1,1) and secondly with either Cy50.5CD10PIBMA39 or Cy31.5CD72PIBMA389 (1 h; 0 °C) to allow further sur-
face functionalization (Fig. 1,2). Cell analysis using confocal microscopy indicated that cell functionalization 
was accomplished using both polymer types (Supplementary Fig. S12). MTT cell-viability tests performed 24 h 
after the (supramolecular) cell-surface functionalization (Supplementary Fig. S13) showed that the cells were not 
negatively affected by the functionalization with Ac-TZ14011-Ad and either one of the two polymers (0–16 μ M 
β -CD).
To further study the CXCR4-receptor specificity of the functionalization process, the experiments were 
repeated with a mixed cell culture of viable MDAMB231 × 4 (with overexpressed CXCR4 receptor and with 
CXCR4-linked GFP-tag) and as a control MDAMB231 cells (with basal CXCR4 expression and without 
CXCR4-linked GFP-tag). We have demonstrated previously that a fluorescent variant of the Ac-TZ14011 peptide 
allows for differentiation between the two cell lines, using their difference in CXCR4 expression levels46. Confocal 
microscopy (Fig. 2) and intensity analysis revealed that the average signal intensities of Cy50.5CD10PIBMA39 
and Cy31.5CD72PIBMA389 were respectively 5 and 8 times higher on the MDAMB231 × 4 cells, compared to the 
signal intensities observed on the cells with basal CXCR4 expression (MDAMB231), which indicates receptor 
specificity.
The influence of host-guest interactions on the degree of cell surface functionalization was examined on 
MDAMB231 × 4 cells. Here for the conditions of the first incubation step were varied as follows; (1) by omitting 
the use of a CXCR4-binding peptide, (2) by using non-Ad functionalized Ac-TZ14011 (includes a lower affin-
ity tyrosine (Tyr10) guest moiety47,48) or (3) via the standard procedure by using Ac-TZ14011-Ad. Differences 
in functionalization using Cy50.5CD10PIBMA39 or Cy50.4PIBMA39 were analyzed using both semi-quantitative 
(confocal microscopy) and quantitative (flow cytometry) methods. Under a direct comparison at baseline the 
non-specific uptake of Cy50.5CD10PIBMA39 is about one-and-a-half times that of Cy50.4PIBMA39, which indi-
cates that β -CD can interact with cell-surface residues. Pre-targeting based introduction of guest moieties on the 
CXCR4 receptors yielded statistically significant (p < 0.01) increases in Cy50.5CD10PIBMA39 binding (Fig. 3a). 
The middle column of Fig. 3a, indicates that the Tyr10 residue on the Ac-TZ14011 peptide (Fig. 1b) already 
induces enhanced binding of the CD-polymer41. The introduction of the higher affinity Ad-guest molecule 
(Ac-TZ14011-Ad), further enhances this effect (Fig. 3a, last column).
When the polymer did not include β -CD (host) functionalizations (Cy50.4PIBMA39), binding was not 
induced by the presence of Ac-TZ14011, or Ac-TZ14011-Ad (Fig. 3b). Figure S15 further illustrates that the 
availability of multiple CD-moieties on the polymer backbone enhances the binding considerably. On average 
Cy50.5CD10PIBMA39 displayed two-fold higher binding than Cy50.4PIBMA39. The findings of Fig. 3a,b and sup-
plementary Fig. S15 combined suggest that both guest and host moieties play an instrumental role in the cell 
functionalization process.
During the (supramolecular) cell surface modification it is expected that one polymer interacts with multiple 
Ac-TZ14011-Ad moieties to establish functionalization. Individual CXCR4 receptors have a diameter of approx-
imately 4 to 5 nm, based on the crystal structure of CXCR4 obtained from the RCSB protein data bank (PDB 
code 3OE0)41. Although the distance between CXCR4 receptors on the membrane is unknown, it is reported that 
they can cluster in groups49,50. When assuming a spherical structure, Cy50.5CD10PIBMA39 has a hydrodynamic 
diameter of 2.8 nm in water but, when unfolded, the polymer length is approximately 24 nm (based on the esti-
mated bond lengths of one subunit, times the number of subunits in the polymer). Hypothetically, this should 
allow simultaneous interactions with multiple (clustered) Ac-TZ14011-Ad functionalized CXCR4 receptors. The 
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longer Cy31.5CD72PIBMA389 polymer (hydrodynamic diameter ~11.7 nm; unfolded > 200 nm) should allow such 
multivalent interactions even more. To test this theory, the functionalization was also performed using monova-
lent Cy5-CD (5) instead of a CDnPIBMAm polymer, which resulted in a substantial lower degree of functionali-
zation (Supplementary Fig. S14). These findings show that multivalent interactions between β -CD-host molecules 
and different Ad-guest molecules are indeed required. Furthermore it confirms the assumption that each polymer 
interacts with at least two or more Ac-TZ14011-Ad functionalized CXCR4 receptors.
Since Cy31.5CD72PIBMA389 differs considerably from Cy50.5CD10PIBMA39 in length (unfolded; 24 
vs. > 200 nm) and in CD number (10 vs. 72), Cy31.5CD72PIBMA389 can, in theory, bind to more Ac-TZ14011-Ad 
groups than Cy50.5CD10PIBMA39. This difference was indeed reflected in the affinity of both polymers for the 
Figure 2. Supramolecular surface modification of viable MDAMB231 × 4 (with CXCR4-linked GFP-
Tag) and MDAMB231 cells (without GFP-Tag) in mixed cell culture. Modification was accomplished via 
specific functionalization of the CXCR4 receptor with Ac-TZ14011-Ad, followed by host-guest interaction 
between β -CD molecules on fluorescent Cy50.5CD10PIBMA39 or Cy31.5CD72PIBMA389 polymers and the Ad 
functionality. Functionalization mainly occurs on the CXCR4 overexpressing MDAMB231 × 4 cells. For clarity, 
both the (overlay) image and the same image at the individual channels are displayed, with GFP in green, Cy5 
(Cy50.5CD10PIBMA39) in red, and Cy3 (Cy31.5CD72PIBMA389) in blue.
Figure 3. Host-guest interaction dependent cellular functionalization: (a) Binding of Cy50.5CD10PIBMA39 
increases in a statistically significant manner when the guest moieties Ac-TZ14011 and Ac-TZ14011-Ad 
become available at the cell surface. (b) Cy50.4PIBMA39 functionalization is not influenced by the availability 
of guest moieties. These values remain at baseline. The degree of functionalization was quantified by Flow 
cytometry (blue) or Confocal microscopy (red). Graphs show the normalized data with the error bars indicating 
the standard deviations (n = 6) and the significance of differences marked with *(p < 0.05) or **(p < 0.01).
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Ad-functionalized cell surfaces. In competition experiments (see supporting information for more detailed 
description and discussion), Cy31.5CD72PIBMA389 bound in slightly larger quantities to the cells surface then 
Cy50.5CD10PIBMA39 (Supplementary Fig. S17). Competition followed over time by confocal microscopy, 
revealed that under competitive conditions Cy31.5CD72PIBMA389 could replace Cy50.5CD10PIBMA39 cell func-
tionalizations, while the reverse proved to be difficult (Supplementary Figs S18 and S19).
To investigate if the observed replacement is indeed based on host-guest interactions, the same longitudinal 
competition experiment was repeated with Cy50.4PIBMA39. This experiment demonstrated that Cy50.4PIBMA39 
was not replaced by Cy31.5CD72PIBMA389, which displayed increased binding to the cell surface over time 
(see supporting information for more detailed description and discussion; Figs S18 and S19). When the reverse 
was attempted, Cy31.5CD72PIBMA389 could also not be replaced by Cy50.4PIBMA39 while the backbone pol-
ymer already displayed binding at an early time-point. These results indicate that the non-specific binding 
of Cy50.4PIBMA39 occurs at a different location than where Cy31.5CD72PIBMA389 binds in a specific man-
ner. These control experiments underline that the observed replacement between Cy50.5CD10PIBMA39 and 
Cy31.5CD72PIBMA389 (Supplementary Figs S18 and S19) represent competition observed in the host-guest inter-
actions between the CD-moieties on the polymers and the Ac-TZ14011-Ad ligands.
Using cells as chemical scaffold for further functionalization. β -CD based binding of the 
PIBMA-polymers to the Ac-TZ14011-Ad functionalized cell surface is dynamic and occurs with the presence 
of an excess of β -CD groups on the polymers (Fig. 4a, step 1, 2). Hence, it is expected that non-bound β -CD 
groups remain available that can be used for consecutive supramolecular functionalization steps. This concept 
was initially studied using Cy5-Ad (6) and Cy5-Ad2 (7). The monovalent Cy5-Ad showed very little staining 
of cells that were pre-functionalized with Cy31.5CD72PIBMA389 (Supplementary Fig. S20). In contrast, the 
bivalent Cy5-Ad2 showed clear staining under identical conditions, providing co-localization of the CXCR4 
Figure 4. (a) Schematic illustration of introducing a third-generation of surface modification, e.g. Cy5-Ad2. 
The host-guest interaction of CD-Ad is dynamic and after functionalizing the cell surface with CDnPIBMAm 
polymers, e.g. Cy31.5CD72PIBMA389 (step 1,2), non-bound β -CD groups should be available to host the second 
fluorescent label (step 3). (b) Confocal images visualizing the introduction of Cy5-Ad2 on Cy31.5CD72PIBMA389 
functionalized MDAMB231 × 4 cells. For clarity, both the (overlay) image and the same image at the individual 
channels are displayed, with GFP in green, Cy3 (Cy31.5CD72PIBMA389) in blue and Cy5 (Cy5-Ad2) in red.
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receptor (GFP), Cy31.5CD72PIBMA389 (Cy3), and Cy5-Ad2 (Cy5) (Fig. 4b). Use of Cy5 (8) alone did not result 
in staining (Supplementary Fig. S20). Moreover, experiments where Cy5-Ad2 was added in the absence of 
Cy31.5CD72PIBMA389, did not yield non-specific staining which is a clear indication that the polymer is essential 
for functionalization (Supplementary Fig. S21). When looking at the binding constant of mono- and bivalent Ad 
with multivalent β -CD hosts in general51–54, a difference of at least a factor 200 is found. The binding constant of 
bis-adamantane (e.g. Cy5-Ad2) with multivalent β -CD hosts lies between 1·107–1·1010 M−1 (depending on the 
host and its environment)52,53, while the Cy5-Ad interaction with Cy31.5CD72PIBMA389 can be seen as a mono-
valent interaction of which the binding constant lies around 5·104 M−1 51,54. Again multivalency seems to be a key 
component for facilitating stable interactions under in vitro conditions. The ability to utilize β -CD functionalized 
cell surfaces to introduce a third-generation of functionalization opens up a scale of functionalization types to 
tailor a wide range of applications. For example, diagnostic labels for cell-tracking55 could be introduced via this 
route. Alternatively, the introduction of therapeutic agents or a combination of both is possible. Hereby cells are 
converted into functional scaffolds that can be applied for delivery applications.
Given the fact that the CDnPIBMAm polymers interact with Ac-TZ14011-Ad functionalization on the cell 
surface and that the secondary polymer surface functionalization enables a third-generation of surface mod-
ifications, we reasoned that it would be of interest to use such technology to drive the interactions between 
MDAMB231 × 4 cells that are either functionalized with CDnPIBMAm polymers or Ac-TZ14011-Ad (Fig. 5a).
To study the induction of cell-cell interactions, Ac-TZ14011-Ad + Cy31.5CD72PIBMA389 functionalized 
adhered MDAMB231 × 4 cells were incubated with a solution containing Ac-TZ14011-Ad functionalized 
Figure 5. (a) Schematic overview of inducing cell-cell interactions (3) between β -CD polymer 
(Cy31.5CD10PIBMA389) functionalized cells (1) and Ad (Ac-TZ14011-Ad) functionalized cells (2) with 
Hoechst staining (white) (b) Representative confocal images of inducing supramolecular cell-cell interactions 
between variable functionalized MDAMB231 × 4 cells. With GFP in green, Cy3 in blue and Hoechst in white. 
(c) Average values of the fraction of cell-cell interactions in each test condition. Significance of differences is 
marked with *(p < 0.05) or **(p < 0.01).
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MDAMB231 × 4 cells in suspension (see Fig. 5a for a schematic representation). In the latter the nucleus was 
stained with Hoechst in order to enable discrimination between the two. After 15–30 min of incubation, cell-cell 
interactions were quantified using confocal microscopy (Fig. 5b). Analysis of the obtained images revealed that on 
average 61% of the Hoechst stained suspended cells within the field of view interacted with non-Hoechst stained 
adherent cells. Control experiments where the adherent cells were not functionalized using Cy31.5CD72PIBMA389 
and/or in which the cells in suspension were not functionalized with Ac-TZ14011-Ad resulted in significantly 
(p < 0.01 and p < 0.05 respectively) lower percentages of cell-cell interactions, as is depicted in Fig. 5. This made 
us conclude that the introduced cell-surface modifications and underlying supramolecular chemistry opens the 
perspective to drive cell-cell interactions.
Synthetic control on cell-cell enhancing interactions could be beneficial for cell-based therapies7–9. For exam-
ple, a challenge in (heart) stem-cell transplantation is to make the cells reside at the site of interest long enough 
to deliver a therapeutic effect10. In the current clinical set-up, for example, cardiac stem cells are quickly cleared 
from location after intramyocardial injection56. If the interaction of a transplanted cell with its surrounding could 
be enhanced, e.g. by providing a “temporary glue-like” adhesion of the cells at the injection site, the local retention 
could be improved. By allowing the cells time to engraft to the host tissue using natural transmembrane recep-
tor interactions, the cellular retention and thus the therapeutic efficacy is likely to be enhanced. Alternatively, 
the same mechanism could be applied to temporarily adhere cells that excrete therapeutic substances such as 
enzymes57. To demonstrate that the technology described is not limited to cancer cells we successfully applied this 
technology on CXCR4 expressing human cardiac stem cells (Supplementary Fig. S22), which are currently used 
in stem cell-therapy. After having established all the chemical requirements for the supramolecular cell-surface 
modification, studies regarding the biological efficacy of functionalized stem cells will be initiated.
The cell-surface modification approach as described in this manuscript, obtains its cell-type specificity from 
the specific targeting of membrane receptors, in this case being CXCR4 (Fig. 1, 1). While polymer modification 
of the cell surface is a generic step (Fig. 1, 2), the introduction of functionalities for e.g. adhesion can again 
be tailored if required. This provides a large degree of (synthetic) freedom and possibilities. With the many 
membrane-receptor targeting vectors available on the market these days38,40,43,58,59, and the huge variety of func-
tionalities that could be of value, the proposed approach can be made compatible with a whole scale of cells and 
cell-therapy applications. The most critical part herein seems to be a high local density of one, or a combination 
of, membrane-receptors so that multivalent interactions with the host polymer are possible.
Based on the possibility of introducing specificity via the membrane-receptors (Fig. 2, 3) it may be postulated 
that the supramolecular approach provides a good alternative for current cell surface functionalization methods, 
such as the layer by layer (LBL) a-specific cell coating by polyelectrolyte polymers18 or the insertion of lipophilic 
anchors20. While the LBL technique has proven its applicability as cell coating on different sturdy cell membranes, 
e.g. bacteria and pancreatic islets60, the supramolecular functionalization is more subtle and allows cell surface 
modification in more sensitive cell types without harming the cell viability (Supplementary Fig. S13).
Methods
General. For information on the materials used and more in depth experimental descriptions (including com-
pound synthesis and analysis, determination of the receptor affinity of Ac-TZ14011-Ad, cell culture and confocal 
microscopy), see the Supporting information (SI).
Polymer synthesis. Poly(isobutylene-alt-maleic anhydride) (PIBMA39, Mw 6,000) or PIBMA389 (Mw 60,000) 
were dissolved in dry DMSO together with DIPEA and the appropriate Cy5- or Cy3-dye. The reaction was left 
to stir for at least 7 h. Then 6-monodeoxy-6-monoamine-β -cyclodextrin (β -CD) was added and the mixture was 
stirred at 80 °C for another 12 h. After cooling to RT, the polymer was dialyzed against H2O for 1 day, then against 
100 mM phosphate buffer pH 9.0 for another day, and finally against H2O for 5 days. The dialysis medium was 
refreshed every day. The remaining solution was then lyophilized to obtain the product. The number of CD 
groups per polymer, was estimated via 1H NMR analysis and the number of dyes per polymer was estimated via 
UV/Vis absorbance (see Supporting information). Prior to use, a solution of 1 mg/mL in H2O each polymer was 
prepared and stored at 4 °C.
Cy50.4 PIBMA39 (compound 2). PIBMA39 (9.1 mg, 1.5 μ mol) and Cy5-Sulfonate-Amine (10) (1 mg, 1.8 μ mol) 
were dissolved in 0.6 mL dry DMSO, DIPEA (13 μ L, 74 μ mol) was added and the mixture was stirred at RT over-
night. Subsequently, the reaction mixture was directly dialyzed and after lyophilization, the product was obtained 
as a blue powder (2 mg, 0.3 μ mol).
Average number of Cy5 dye/polymer according UV/vis absorbance: 0.4
Estimated molecular weight: 7.8 kDa (Table S1).
Cy50.5CD10PIBMA39 (compound 3). PIBMA39 (30 mg, 5 μ mol) and Cy5-(SO3)Sulfonate-(SO3)Amine (9) 
(5.0 mg, 5.6 μ mol) were dissolved in 3 mL dry DMSO and DIPEA (50 μ L, 250 μ mol) was added. The reaction was 
stirred at 80 °C for 7 h, then 6-monodeoxy-6-monoamino-β -cyclodextrin (95 mg, 80 μ mol) was added and the 
solution was stirred for another 72 h at 80 °C. After dialysis and lyophilization, the product was obtained as a blue 
powder (87 mg, 5 μ mol).
Average number of CD groups/polymer according 1H NMR: 10
Average number of Cy5 dye/polymer according UV/vis absorbance: 0.5
Estimated molecular weight: 18.8 kDa (Table S1).
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Cy31.5CD72PIBMA389 (compound 4). PIBMA389 (10 mg, 0.17 μ mol) and DIPEA (15 μ L, 85 μ mol) were dissolved 
in 1.7 mL dry DMSO and a solution of Cy3-Amine-COOH (11) in dry DMSO (0.25 mM, 800 μ L, 0.2 μ mol) was 
added. The reaction was stirred overnight at RT, then, 6-monodeoxy-6-monoamino-β -cyclodextrin (31.6 mg, 
27 μ mol) was added and the solution was stirred for another night at 80 °C. After dialysis and lyophilization the 
product was obtained as a bright pink powder (22.3 mg, 0.16 μ mol).
Average number of CD groups/polymer according 1H NMR: 72
Average number of Cy3 dye/polymer according UV/vis absorbance: 1.5
Estimated molecular weight: 155 kDa (Table S2).
Cell experiments. Functionalization of cells. MDAMB231 × 4, were seeded onto culture dishes (80,000 per 
dish) and brought to 0 °C, followed by incubation with Ac-TZ14011-Ad (10 μ M) in 1 mL DMEM for 1 h at 0 °C. 
Subsequently, either Cy50.5CD10PIBMA39 or Cy31.5CD72PIBMA389 was added (10 μ M final β -CD concentration). 
After 1 h of incubation at 0 °C, cells were washed twice with PBS and confocal images were taken.
Functionalization of cells in a mixed cell-culture. A mixed-cell set-up was used to determine the specificity of 
the cell functionalization. A mixture of 40,000 cells of each strain of MDAMB231 × 4 and MDAMB231 cells 
were seeded. The next day, the cells were brought to 0 °C and subsequently they were functionalized with either 
Cy50.5CD10PIBMA39 or Cy31.5CD72PIBMA389 (see functionalization of the cells). During confocal analysis dis-
crimination between the fluorescence of the outer membrane of the two cell lines was based on the GFP signal, 
only present in the MDAMB231 × 4 strain. To determine the difference in polymer binding to Ac-TZ14011-Ad 
functionalized MDAMB231 × 4 and MDAMB231 cells, the experiment was performed twice and for each cell 
type the average gray value/m2 of 25 cells in total were measured (see SI for further details).
Ac-TZ14011-Ad induced cell functionalization analyzed by confocal microscopy. The receptor-mediated func-
tionalization of cells was examined by confocal microscopy and flow cytometry (see also ‘Ac-TZ14011-Ad 
induced cell functionalization analyzed by flow cytometry’). For Confocal microscopy MDAMB231 × 4 cells 
(80,000 per well) were incubated with either Ac-TZ14011 (10 μ M), Ac-TZ14011-Ad (10 μ M), or none, for 1 h at 
0 °C in 1 mL DMEM. Subsequently, either Cy50.4PIBMA39 or Cy50.5CD10PIBMA39 was added (10 μ M β -CD; 1 μM 
polymer final concentration) and another hour at 0 °C of incubation followed. Thereafter, the cells were washed 
twice with PBS and confocal images were acquired. All experiments were performed in 6-fold and for each condi-
tion per experiment at least 10 cells were included in the study. The Cy5 signal present on the cell in each sample 
was quantified to analyze differences between the amount of binding of the polymers to the cells when either, no 
peptide, Ac-TZ14011, or Ac-TZ14011-Ad was present. For normalization all results were divided by the average 
fluorescence value obtained when just the polymer was added. The significance of the obtained differences was 
determined by student T-test (two tailed, unpaired).
Cy5-Ad and Cy5-Ad2 functionalization of polymer modified cell surfaces. A third functionalization on the 
β -CD-polymer functionalized cells was introduced, by first functionalizing adherent MDAMB231 × 4 cells 
with Cy31.5CD72PIBMA389. Subsequently, the cells were washed once with DMEM, followed by incubation with 
Cy5-Adn (n = 1 or 2, 5 μ M) in 1 mL DMEM for 1 h at 0 °C. Before confocal images were taken, the cells were 
washed twice with PBS. As a control experiment, the cells were incubated with Cy5-Ad2 (5 μ M final concentra-
tion) while the polymer was omitted in the first incubation step.
Cell-cell interactions. To study cell-cell interactions, variable combinations of functionalized MDAMB231 × 4 
cells were evaluated. MDAMB231 × 4 cells (300,000 per tube) in suspension were incubated with Hoechst 33342 
(1 μ g/mL) for 30 minutes in 1 mL DMEM at 0 °C. Subsequently, they were washed once with PBS (centrifuged 
3 min, 3000 × g, 4 °C), cooled on ice and either incubated with Ac-TZ14011-Ad (11 μ M) or none, in DMEM 
(500 μ L) for 1 h at 0 °C. After washing twice with PBS (centrifuged 3 min, 3000 × g, 4 °C), cells were resuspended 
in 300 μ L PBS and added to a separate batch of adherent MDAMB231 × 4 target cells (80,000 cells per dish). The 
latter were either functionalized with Cy31.5CD72PIBMA389 or none, and subsequently washed with PBS. The 
variable cell mixtures, see Table S1, were allowed to incubate in 1 mL PBS for 15 to 30 min at RT. Prior to imaging, 
the excess of unbound cells in suspension were gently washed away with PBS (2 × 1 mL, RT).
The samples were examined under confocal microscopy in a culture dish, of each sample approximately 10 
images were acquired at randomly chosen locations. All experiments were performed in 5-fold, resulting in the 
analysis of 223 ± 30 cells per cell combination. For each image obtained, the ratio between Hoechst stained cells 
that had an interaction with a target cell and the total number of Hoechst-stained cells in the image, was calcu-
lated. Obtained ratio’s for each cell combination (Table 1) were averaged and statistical significance of differences 
between each cell combination determined using student T-test (two tailed, unpaired).
Ac-TZ14011-Ad induced cell functionalization analyzed by flow cytometry. Besides examining the 
receptor-mediated functionalization of cells by confocal microscopy (see ‘Ac-TZ14011-Ad induced cell func-
tionalization analyzed by confocal microscopy’) the functionalization was also examined by flow cytometry to 
quantify the rate of functionalization. For this purpose, MDAMB231 × 4 cells were trypsinized and divided into 
aliquots (300,000 cells per tube), centrifuged for three minutes (3000 × g, 4 °C), and supernatant was decanted. 
The cells were incubated with 50 μ L PBS containing either Ac-TZ14011 (10 μ M), Ac-TZ14011-Ad (10 μ M), or 
none for 1 h at 0 °C. Subsequently, 50 μ L of either Cy50.4PIBMA39 or Cy50.5CD10PIBMA39 in PBS was added 
(10 μ M β -CD; 1 μ M polymer final concentration) and another hour at 0 °C of incubation followed. The cells were 
washed twice with PBS (centrifuged 3 min, 3000 × g, 4 °C), resuspended in 300 μ L PBS and the intensity of Cy5 
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fluorescence related to the cells was measured by flow cytometry (see ESI for further details). All experiments 
were performed in 8-fold. For data normalization, all results were divided by the average fluorescence value 
obtained when only the polymer was added. The significance of the obtained differences was determined by stu-
dent T-test (two tailed, unpaired).
Conclusions
In this study we have shown that cell specific sequential surface functionalization could be accomplished by 
pre-targeting cells with an Ad-containing targeting vector such as Ac-TZ14011-Ad. This pre-targeting approach 
provides the possibility of tailoring this first step towards other cell types. Subsequently, host-guest interactions 
between fluorescent labeled CDnPIBMAm host polymers and the introduced Ad-guest functionality not only 
enable surface coating, but also formed a basis for further hierarchical functionalization.
The described host-guest approach adds the possibility to introduce specific functionalizations on the 
CDnPIBMAm modified cell surface. There are always non-bound β -CD groups available for further functionali-
zation, since the polymers contain an access of β -CD groups. The specific functionalizations can be in the form of 
diagnostic- and/or therapeutic-labels, so that the cells become vehicles for imaging and/or drug-delivery applica-
tions. In addition, we have shown that theses supramolecular functionalizations provide a basis to drive cell-cell 
interactions that could prove to be of future benefit for cell based therapies.
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